AIMS Financial Group, one of the premier non-bank financial institution in Australia, today enter into an agreement with its Chinese partner Beijing University as well as Sino Bioway Group to establish a Biotechnology Fund in China. PM Kevin Rudd, who is in China For 2008 Beijing Olympics games also attended signing ceremony.
There has been an encouraging progress in terms of bilateral trading and investment between China and Australia in the past a few years. During PM Kevin Rudd’s first trip to China in April this year as the new Primer Minster of Australia, he made a speech which clearly encourages and promotes the biotech and financial services industry between China and Australia. In fact, there is a great potential for two countries to cooperate within the biotechnology and financial industries given the broad marketing needs from China.
After elaborated discussion and preparation, both AIMS Financial Group and Beijing university agree to make a long-term strategy cooperation partnership. According to the Memorandum of cooperation signed today, AIMS and its Chinese partners will start to establish a Biotechnology Fund named AIMS Bei Da Biotech China Fund (ABDC).
The first step is to set up a Funds Management Company with proposed name AIMS Bei Da Biotech Funds Management Company in China where it will be a Joint Venture between AIMS Financial Group and the Beijing University. Then this Fund Management Company will act as the fund Manager for ABDC once the necessary Chinese Government approvals are received.
The Fund will be professionally managed in strict compliance with international Funds Management Standards, mainly focusing on investment into China/Australian for bio technology infrastructure development. Potential investors include government agencies, large corporate , institutional , professional and individual investors.
In the meantime, ABDB will also start to set up an international Biotech Fund offering investment opportunities to both Australian and global investors , and this international fund will also invest into Australian Biotechnology Sector.
The Australian Fund Partner, AIMS Financial Group was established in 1991 in Sydney Australia. It is a non- bank financial institution with a solid track record, and holds an Australia Financial Service License for real estate funds manager and mortgage funds manager, and also it is a license holder for securitization trust manager. The License is granted by the Australian Securities and Investments Commission (ASIC). AIMS has expended to become an international financial group focusing on Funds Management, Investment Banking, Real Estate & Resource Investment, eCommerce, Securitization and Mortgage Lending. AIMS’ manage team includes worldwide top financial industry specialists, who have a strong experience and track record in financial innovation, project and risk management.
AIMS Financial Group has strong business network and proven investment experience in securitization and mortgage markets. It is one of the earliest non-financial group has operated securitization. In the 7 years to 2007, AIMS has raised directly and indirectly around AUD 3 Billion in funds from capital markets, with most of the RMBS rated AAA by both Standard& Poor and Fitch Ratings.
With offices across Australia and China, and representations in Hong Kong, AIMS Financial Group has a strong physical presence in the Australasian region. Together with our highly qualified, professional and experienced cross-cultural teams, AIMS Financial Group is in a very strong position to bridging the gap between Australia and China.
The Sino Bioway Group, the Chinese Partner, is a large leading bio-tech engineering group in China, dedicating themselves to research and development across the Bio-tech, Bio-intelligence and Personalised Medical industries. As a leader in China Bio-Pharmaceutical industry, Sino Bioway Group has been striving for promoting the development and advancement of Chinese Bio-Tech industry.
With the formation of the Bio-Tech Fund, a platform utilizing the strength from both sides can now be built. According to the analysis from experts, given the investment guidelines of the Fund, the existance of the Fund will effectively resolve the fund-raising problem of Chinese bio-tech companies. Those fast-growing bio-tech companies with great potential will be brought into the investment portfolio of this fund and can then develop rapidly with the support of necessary funding.
The signing ceremony is highly regarded by Australian and Chinese governments as well as fund partners. The CEO of AIMS Financial Group, Mr. George Wang, along with several senior executives, arrived in Beijing for signing ceremony. Mr. ZhiHong Xu, Chancellor of Beijing University, and Mr. Aihua Pan, Chairman of Sino Bioway Group represent the Chinese partner. The signing ceremony was jointly hosted by Mr. George Wang and Mr. Aihua Pan. The Prime Minister of Australia, Mr. Kevin Rudd, witnessed this historical moment. In addition, Mr Simon Crean, Minister of Trade, Mr Peter O’Byrne, CEO Austrade and other officials in Australian embassy attended the ceremony.